![Zohar Koren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zohar Koren
Amministratore Delegato presso
SciCann Therapeutics, Inc.
Profilo
Dr. Zohar Koren is a Chief Executive Officer at OncoDecipher Ltd., a Chief Technology Officer at Xinteza API Ltd. and a Chief Executive Officer at SciCann Therapeutics, Inc. Dr. Koren was previously employed as a Chief Executive Officer & Director by Cannabics Pharmaceuticals, Inc. and a Founder by Cannabics, Inc. He also served on the board at Alterola Biotech, Inc. (California).
He received his undergraduate degree from The Hebrew University of Jerusalem, a graduate degree from the University of Haifa and a doctorate degree from the University of Haifa.
Posizioni attive di Zohar Koren
| Società | Posizione | Inizio |
|---|---|---|
SciCann Therapeutics, Inc.
 SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Amministratore Delegato | - |
Xinteza API Ltd.
 Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Fondatore | 17/03/2019 |
Oncodecipher
 Oncodecipher Packaged SoftwareTechnology Services Develops a AI powered platform designed to detect and analyze novel genetic variations as biomarkers for therapies | Amministratore Delegato | 01/02/2024 |
Precedenti posizioni note di Zohar Koren
| Società | Posizione | Fine |
|---|---|---|
| CNBX PHARMACEUTICALS INC. | Fondatore | 23/01/2015 |
| ALTEROLA BIOTECH, INC. | Direttore/Membro del Consiglio | - |
Cannabics, Inc.
 Cannabics, Inc. Financial ConglomeratesFinance Provides cannabinoid-based therapy through its subsidiary | Fondatore | - |
Formazione di Zohar Koren
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
6
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
CNBX Pharmaceuticals, Inc.
 CNBX Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer | Health Technology |
Alterola Biotech, Inc. (California)
 Alterola Biotech, Inc. (California) Chemicals: SpecialtyProcess Industries Manufactures medicament containing chewing gums | Process Industries |
Cannabics, Inc.
Cannabics, Inc. Financial ConglomeratesFinance Provides cannabinoid-based therapy through its subsidiary | Finance |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Haifa
 University of Haifa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xinteza API Ltd.
Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
SciCann Therapeutics, Inc.
SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Oncodecipher
Oncodecipher Packaged SoftwareTechnology Services Develops a AI powered platform designed to detect and analyze novel genetic variations as biomarkers for therapies | Technology Services |
